| Name | Title | Contact Details |
|---|
ABK Biomedical Inc. combines a compelling clinical market need with innovative biomaterials invented by Drs. Bob Abraham, Daniel Boyd and Sharon Kehoe.
Amkai is a Armonk, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kryptiq is the leading provider of interoperability and workflow connectivity solutions for healthcare.
Mission Healthcare is a provider of home-based healthcare and hospice services in Southern California. They offer a wide range of professional healthcare and support services provided in the home, including home health, home care, and hospice.
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.